Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-concentration sevoflurane plus auricular vagus nerve stimulation for social impairment in children with ASD
ChiCTR2600119672Phase 4Not yet recruiting
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sevoflurane in Autism Spectrum Disorder (ASD), sponsored by Nanjing Drum-Tower Hospital. Primary endpoint: Aberrant Behavior Checklist - Social Withdrawal subscale score. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
sevoflurane
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on ChiCTR2600119672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600119672.